Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Achieve Life Sciences stock

Own Achieve Life Sciences stock in just a few minutes.

Achieve Life Sciences, Inc is a biotechnology business based in the US. Achieve Life Sciences shares (ACHV) are listed on the NASDAQ and all prices are listed in US Dollars. Achieve Life Sciences employs 13 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Achieve Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACHV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Achieve Life Sciences share price

Use our graph to track the performance of ACHV stocks over time.

Achieve Life Sciences shares at a glance

Information last updated 2021-04-30.
52-week range$6.60 - $18.26
50-day moving average $11.31
200-day moving average $10.29
Wall St. target price$45.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.61

Buy Achieve Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Achieve Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Achieve Life Sciences financials

Gross profit TTM $0
Return on assets TTM -30.04%
Return on equity TTM -53.24%
Profit margin 0%
Book value $6.10
Market capitalisation $66.4 million

TTM: trailing 12 months

Shorting Achieve Life Sciences shares

There are currently 468,643 Achieve Life Sciences shares held short by investors – that's known as Achieve Life Sciences's "short interest". This figure is 2.1% up from 458,921 last month.

There are a few different ways that this level of interest in shorting Achieve Life Sciences shares can be evaluated.

Achieve Life Sciences's "short interest ratio" (SIR)

Achieve Life Sciences's "short interest ratio" (SIR) is the quantity of Achieve Life Sciences shares currently shorted divided by the average quantity of Achieve Life Sciences shares traded daily (recently around 73570.32967033). Achieve Life Sciences's SIR currently stands at 6.37. In other words for every 100,000 Achieve Life Sciences shares traded daily on the market, roughly 6370 shares are currently held short.

However Achieve Life Sciences's short interest can also be evaluated against the total number of Achieve Life Sciences shares, or, against the total number of tradable Achieve Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Achieve Life Sciences's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Achieve Life Sciences shares in existence, roughly 80 shares are currently held short) or 0.0764% of the tradable shares (for every 100,000 tradable Achieve Life Sciences shares, roughly 76 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Achieve Life Sciences.

Find out more about how you can short Achieve Life Sciences stock.

Achieve Life Sciences share dividends

We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months.

Have Achieve Life Sciences's shares ever split?

Achieve Life Sciences's shares were split on a 1:20 basis on 30 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.

Achieve Life Sciences share price volatility

Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $6.6 up to $18.26. A popular way to gauge a stock's volatility is its "beta".

ACHV.US volatility(beta: 1.29)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.2897. This would suggest that Achieve Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Achieve Life Sciences overview

Achieve Life Sciences, Inc. , a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada. .

Frequently asked questions

What percentage of Achieve Life Sciences is owned by insiders or institutions?
Currently 0.453% of Achieve Life Sciences shares are held by insiders and 18.845% by institutions.
How many people work for Achieve Life Sciences?
Latest data suggests 13 work at Achieve Life Sciences.
When does the fiscal year end for Achieve Life Sciences?
Achieve Life Sciences's fiscal year ends in December.
Where is Achieve Life Sciences based?
Achieve Life Sciences's address is: 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
What is Achieve Life Sciences's ISIN number?
Achieve Life Sciences's international securities identification number is: US0044685008
What is Achieve Life Sciences's CUSIP number?
Achieve Life Sciences's Committee on Uniform Securities Identification Procedures number is: 004468104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site